Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | MDT Medtronic | ABT Abbott Laboratories |
|---|---|---|
| Price | $92.13 -0.7% | $102.61 +0.4% |
| StockIQ Score | 63C+ Moderate Risk: Medium | 51C- Moderate Risk: Medium |
| Technical | 65B- | 19F |
| Fundamental | 67B- | 72B |
| Growth | 58C | 45D+ |
| Fair Value | 38F | 38F |
| News | 100A+ | 100A+ |
| Quality | 63C+ | 63C+ |
| Risk | 54C- | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Medtronic (MDT) outperforms Abbott Laboratories (ABT) in investor, technical and growth scores, with 63 vs 51, 65 vs 19, and 58 vs 45 respectively. Abbott leads on the fundamental score, 72 compared with 67 for Medtronic. Both have the same valuation score of 38.